These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35941801)

  • 1. [A Patient Developing Guillain-Barré Syndrome After Receiving the BNT162b2 COVID-19 mRNA Vaccine].
    Oshibe N; Honda M; Koga M; Sato R; Oishi M; Kanda T
    Brain Nerve; 2022 Aug; 74(8):1025-1030. PubMed ID: 35941801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré Syndrome Following the BNT162b2 mRNA COVID-19 Vaccine.
    Algahtani HA; Shirah BH; Albeladi YK; Albeladi RK
    Acta Neurol Taiwan; 2023 Jun; 32(2)():82-85. PubMed ID: 37198513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.
    Hanson KE; Goddard K; Lewis N; Fireman B; Myers TR; Bakshi N; Weintraub E; Donahue JG; Nelson JC; Xu S; Glanz JM; Williams JTB; Alpern JD; Klein NP
    JAMA Netw Open; 2022 Apr; 5(4):e228879. PubMed ID: 35471572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination.
    Ogata S; Ishii Y; Asano K; Kobayashi E; Kubota S; Takahashi K; Miyaji Y; Higashiyama Y; Joki H; Doi H; Koga M; Takeuchi H; Tanaka F
    Intern Med; 2022 Jun; 61(11):1757-1760. PubMed ID: 35342134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré Syndrome.
    Hilts A; Schreiber A; Singh A
    Am J Case Rep; 2022 Aug; 23():e936896. PubMed ID: 35945825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of polyneuropathy after COVID-19 vaccine].
    Iseki M; Nakayama H; Watanabe M; Uchibori A; Chiba A; Mizutani S
    Rinsho Shinkeigaku; 2022 Jul; 62(7):558-562. PubMed ID: 35753790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré Syndrome Following the mRNA COVID-19 Vaccination: Comment.
    Mungmunpuntipantip R; Wiwanitkit V
    Acta Neurol Taiwan; 2023 Dec; 32(4)():228-229. PubMed ID: 37781729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post COVID-19 vaccine Guillain-Barré syndrome.
    Khadka B; Khanal K
    J Nepal Health Res Counc; 2022 Mar; 19(4):852-854. PubMed ID: 35615850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine.
    García-Grimshaw M; Michel-Chávez A; Vera-Zertuche JM; Galnares-Olalde JA; Hernández-Vanegas LE; Figueroa-Cucurachi M; Paredes-Ceballos O; Reyes-Terán G; Carbajal-Sandoval G; Ceballos-Liceaga SE; Arauz A; Valdés-Ferrer SI
    Clin Immunol; 2021 Sep; 230():108818. PubMed ID: 34358692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant protein subunit COVID-19 vaccine-induced Guillain-Barré Syndrome in an adolescent: A case report.
    Rohilla R; Kakkar AK; Divyashree K; Mohindra R; Suri V
    Br J Clin Pharmacol; 2023 Feb; 89(2):556-560. PubMed ID: 35856283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of sensory ataxic Guillain-Barré syndrome with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19 vaccine BNT162b2 (Pfizer).
    Fukushima T; Tomita M; Ikeda S; Hattori N
    QJM; 2022 Jan; 115(1):25-27. PubMed ID: 34871447
    [No Abstract]   [Full Text] [Related]  

  • 12. Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine.
    Trimboli M; Zoleo P; Arabia G; Gambardella A
    Neurol Sci; 2021 Nov; 42(11):4401-4402. PubMed ID: 34346014
    [No Abstract]   [Full Text] [Related]  

  • 13. Case of Guillain-Barré syndrome following COVID-19 vaccine.
    Hasan T; Khan M; Khan F; Hamza G
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34187803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
    Oo WM; Giri P; de Souza A
    J Neuroimmunol; 2021 Nov; 360():577719. PubMed ID: 34560365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination.
    Aomar-Millán IF; Martínez de Victoria-Carazo J; Peregrina-Rivas JA; Villegas-Rodríguez I
    Rev Clin Esp (Barc); 2021 Nov; 221(9):555-557. PubMed ID: 34593364
    [No Abstract]   [Full Text] [Related]  

  • 16. Two possible etiologies of Guillain-Barré syndrome: mRNA-1273 (Moderna) vaccination and scrub typhus: A case report.
    Hwang BW; Bong JB
    Medicine (Baltimore); 2022 Dec; 101(48):e32140. PubMed ID: 36482517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic capillary leak syndrome (SCLS) after receiving BNT162b2 mRNA COVID-19 (Pfizer-BioNTech) vaccine.
    Inoue M; Yasue Y; Kobayashi Y; Sugiyama Y
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35292552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2.
    Shapiro Ben David S; Potasman I; Rahamim-Cohen D
    JAMA Neurol; 2021 Nov; 78(11):1409-1411. PubMed ID: 34468703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolated facial diplegia as an atypical variant of Guillain-Barre syndrome after suspected SARS-CoV-2 infection].
    Lavilla Olleros C; López-Rubio M; Fanciulli C; González-Munera A; Millán Núñez-Cortés J
    Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):405-407. PubMed ID: 34962738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Guillain-Barré syndrome variant with prominent facial diplegia.
    Susuki K; Koga M; Hirata K; Isogai E; Yuki N
    J Neurol; 2009 Nov; 256(11):1899-905. PubMed ID: 19633904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.